Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|4|2|75-78

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.4, Iss.2, 2009-05, pp. : 75-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases

By  

Cardiology, Vol. 97, Iss. 2, 2002-04 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Effect of Intranasal Administration of CV-11974, a Type 1 Angiotensin II Receptor Antagonist, on Airway Hyperresponsiveness and Airway Inflammation Induced by Antigen Inhalation in Guinea Pigs

By  

International Archives of Allergy and Immunology, Vol. 129, Iss. 1, 2002-09 ,pp. : 86-92

Karger

Access to resources Recommend Favorite

Effect of N-(Biphenylyl-Methyl)Imidazole, a Type 1 Angiotensin II Receptor Inhibitor,on the Co ntractile Function of the Rat Corpus cavernosum

By  

Urologia Internationalis, Vol. 64, Iss. 3, 2000-06 ,pp. : 149-153

Karger

Access to resources Recommend Favorite

Reperfusion-Induced Arrhythmias Are Suppressed by Inhibition of the Angiotensin II Type 1 Receptor

By  

Cardiology, Vol. 99, Iss. 2, 2003-04 ,pp. : 61-67

Karger

Access to resources Recommend Favorite

Protective effects of the angiotensin type 1 receptor antagonist losartan in infection‐induced and arthritis‐associated alveolar bone loss

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 50, Iss. 6, 2015-12 ,pp. : 814-823

John Wiley & Sons Inc

Access to resources Recommend Favorite